Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_assertion type Assertion NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_head.
- NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_assertion description "[Reliable studies on animal models indicate that the proteolytic break-down products of apolipoprotein[a] would posses anti-angiogenic and anti-tumoral properties both in vitro and in vivo, a premise to develop novel therapeutic modalities which may efficiently suppress tumor growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_provenance.
- NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_assertion evidence source_evidence_literature NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_provenance.
- NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_assertion SIO_000772 17442497 NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_provenance.
- NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_assertion wasDerivedFrom befree-20150227 NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_provenance.
- NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_assertion wasGeneratedBy ECO_0000203 NP538962.RAd2H11IMKYcay1TRhlT35JI-ShmjCU6gnoTSzUxx-BnU130_provenance.